Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients With VT/VF

NCT03871231 is registered in ClinicalTrials.gov with Cardialen, Inc. as lead sponsor.

NCT NCT03871231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03871231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients With VT/VF
Lead sponsor
Cardialen, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
July 17, 2019
Completion date
July 15, 2021
Enrollment
8 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular fibrillation, ventricular tachycardia